Bicycle Therapeutics plc Operating Lease Liability
Bicycle Therapeutics plc (BCYC) had Operating Lease Liability of $14.45 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-07-30
- 2026-06-30: Operating Lease, Liability $14.45M.
- 2026-03-31: Operating Lease, Liability $15.13M.
- 2025-12-31: Operating Lease, Liability $16.65M.
- 2025-09-30: Operating Lease, Liability $5.54M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $14.45M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $15.13M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $16.65M 10-K · filed 2026-03-17 |
| 2025-09-30 | $5.54M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $7.00M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $8.14M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $9.32M 10-K · filed 2025-02-25 |
| 2024-09-30 | $10.90M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $11.83M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $13.02M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $14.26M 10-K · filed 2024-02-20 |
| 2023-09-30 | $15.08M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $16.56M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $19.05M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $14.01M 10-K · filed 2023-02-28 |
| 2022-09-30 | $13.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $15.40M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |